152 related articles for article (PubMed ID: 31562255)
1. Quantitative High-Throughput Screening Using an Organotypic Model Identifies Compounds that Inhibit Ovarian Cancer Metastasis.
Kenny HA; Lal-Nag M; Shen M; Kara B; Nahotko DA; Wroblewski K; Fazal S; Chen S; Chiang CY; Chen YJ; Brimacombe KR; Marugan J; Ferrer M; Lengyel E
Mol Cancer Ther; 2020 Jan; 19(1):52-62. PubMed ID: 31562255
[TBL] [Abstract][Full Text] [Related]
2. Quantitative high throughput screening using a primary human three-dimensional organotypic culture predicts in vivo efficacy.
Kenny HA; Lal-Nag M; White EA; Shen M; Chiang CY; Mitra AK; Zhang Y; Curtis M; Schryver EM; Bettis S; Jadhav A; Boxer MB; Li Z; Ferrer M; Lengyel E
Nat Commun; 2015 Feb; 6():6220. PubMed ID: 25653139
[TBL] [Abstract][Full Text] [Related]
3. Use of a novel 3D culture model to elucidate the role of mesothelial cells, fibroblasts and extra-cellular matrices on adhesion and invasion of ovarian cancer cells to the omentum.
Kenny HA; Krausz T; Yamada SD; Lengyel E
Int J Cancer; 2007 Oct; 121(7):1463-72. PubMed ID: 17546601
[TBL] [Abstract][Full Text] [Related]
4. The metastatic capacity of high-grade serous ovarian cancer cells changes along disease progression: inhibition by mifepristone.
Ritch SJ; Noman ASM; Goyeneche AA; Telleria CM
Cancer Cell Int; 2022 Dec; 22(1):397. PubMed ID: 36494669
[TBL] [Abstract][Full Text] [Related]
5. The Natural Product β-Escin Targets Cancer and Stromal Cells of the Tumor Microenvironment to Inhibit Ovarian Cancer Metastasis.
Kenny HA; Hart PC; Kordylewicz K; Lal M; Shen M; Kara B; Chen YJ; Grassl N; Alharbi Y; Pattnaik BR; Watters KM; Patankar MS; Ferrer M; Lengyel E
Cancers (Basel); 2021 Aug; 13(16):. PubMed ID: 34439084
[TBL] [Abstract][Full Text] [Related]
6. A Specific Mixture of Nutrients Suppresses Ovarian Cancer A-2780 Tumor Incidence, Growth, and Metastasis to Lungs.
Roomi MW; Kalinovsky T; Rath M; Niedzwiecki A
Nutrients; 2017 Mar; 9(3):. PubMed ID: 28335466
[TBL] [Abstract][Full Text] [Related]
7. ETS1 induction by the microenvironment promotes ovarian cancer metastasis through focal adhesion kinase.
Tomar S; Plotnik JP; Haley J; Scantland J; Dasari S; Sheikh Z; Emerson R; Lenz D; Hollenhorst PC; Mitra AK
Cancer Lett; 2018 Feb; 414():190-204. PubMed ID: 29174800
[TBL] [Abstract][Full Text] [Related]
8. A High-Throughput Screening Model of the Tumor Microenvironment for Ovarian Cancer Cell Growth.
Lal-Nag M; McGee L; Guha R; Lengyel E; Kenny HA; Ferrer M
SLAS Discov; 2017 Jun; 22(5):494-506. PubMed ID: 28346091
[TBL] [Abstract][Full Text] [Related]
9. Modeling the Early Steps of Ovarian Cancer Dissemination in an Organotypic Culture of the Human Peritoneal Cavity.
Peters PN; Schryver EM; Lengyel E; Kenny H
J Vis Exp; 2015 Dec; (106):e53541. PubMed ID: 26780294
[TBL] [Abstract][Full Text] [Related]
10. A new 3D organotypic model of ovarian cancer to help evaluate the antimetastatic activity of RAPTA-C conjugated micelles.
Lu M; Henry CE; Lai H; Khine YY; Ford CE; Stenzel MH
Biomater Sci; 2019 Mar; 7(4):1652-1660. PubMed ID: 30724288
[TBL] [Abstract][Full Text] [Related]
11. The Mini-Organo: A rapid high-throughput 3D coculture organotypic assay for oncology screening and drug development.
Chitty JL; Skhinas JN; Filipe EC; Wang S; Cupello CR; Grant RD; Yam M; Papanicolaou M; Major G; Zaratzian A; Da Silva AM; Tayao M; Vennin C; Timpson P; Madsen CD; Cox TR
Cancer Rep (Hoboken); 2020 Feb; 3(1):e1209. PubMed ID: 32671954
[TBL] [Abstract][Full Text] [Related]
12. Collagen Remodeling in the Hypoxic Tumor-Mesothelial Niche Promotes Ovarian Cancer Metastasis.
Natarajan S; Foreman KM; Soriano MI; Rossen NS; Shehade H; Fregoso DR; Eggold JT; Krishnan V; Dorigo O; Krieg AJ; Heilshorn SC; Sinha S; Fuh KC; Rankin EB
Cancer Res; 2019 May; 79(9):2271-2284. PubMed ID: 30862717
[TBL] [Abstract][Full Text] [Related]
13. IL-13 regulates cancer invasion and metastasis through IL-13Rα2 via ERK/AP-1 pathway in mouse model of human ovarian cancer.
Fujisawa T; Joshi BH; Puri RK
Int J Cancer; 2012 Jul; 131(2):344-56. PubMed ID: 21858811
[TBL] [Abstract][Full Text] [Related]
14. Organotypic 3D Models of the Ovarian Cancer Tumor Microenvironment.
Watters KM; Bajwa P; Kenny HA
Cancers (Basel); 2018 Aug; 10(8):. PubMed ID: 30096959
[TBL] [Abstract][Full Text] [Related]
15. Multifunctional APJ Pathway Promotes Ovarian Cancer Progression and Metastasis.
Neelakantan D; Dogra S; Devapatla B; Jaiprasart P; Mukashyaka MC; Janknecht R; Dwivedi SKD; Bhattacharya R; Husain S; Ding K; Woo S
Mol Cancer Res; 2019 Jun; 17(6):1378-1390. PubMed ID: 30858172
[TBL] [Abstract][Full Text] [Related]
16. Cadherin composition and multicellular aggregate invasion in organotypic models of epithelial ovarian cancer intraperitoneal metastasis.
Klymenko Y; Kim O; Loughran E; Yang J; Lombard R; Alber M; Stack MS
Oncogene; 2017 Oct; 36(42):5840-5851. PubMed ID: 28628116
[TBL] [Abstract][Full Text] [Related]
17. Suppression of human ovarian carcinoma metastasis by the metastasis-suppressor gene, BRMS1.
Zhang S; Lin QD; DI W
Int J Gynecol Cancer; 2006; 16(2):522-31. PubMed ID: 16681721
[TBL] [Abstract][Full Text] [Related]
18. M2-like tumor-associated macrophages-secreted EGF promotes epithelial ovarian cancer metastasis via activating EGFR-ERK signaling and suppressing lncRNA LIMT expression.
Zeng XY; Xie H; Yuan J; Jiang XY; Yong JH; Zeng D; Dou YY; Xiao SS
Cancer Biol Ther; 2019; 20(7):956-966. PubMed ID: 31062668
[No Abstract] [Full Text] [Related]
19. Cooperation therapy between anti-growth by photodynamic-AIEgens and anti-metastasis by small molecule inhibitors in ovarian cancer.
Dai J; Xu M; Wang Q; Yang J; Zhang J; Cui P; Wang W; Lou X; Xia F; Wang S
Theranostics; 2020; 10(5):2385-2398. PubMed ID: 32104509
[TBL] [Abstract][Full Text] [Related]
20. Mifepristone inhibits ovarian cancer cell growth in vitro and in vivo.
Goyeneche AA; Carón RW; Telleria CM
Clin Cancer Res; 2007 Jun; 13(11):3370-9. PubMed ID: 17545545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
